Measurements of androgenicity. The spectrum of progestogen activity.
The problem with applying information on progestogen potency obtained from biologic testing to clinical prescribing practices is that the changes in potency relate to more than progestogen dosage. The spectrum of progestogen activity is discussed, with an emphasis on the effects of the progestogens used in oral contraceptive therapy.
D000152:Acne Vulgaris / Q000188:drug therapy; D000726:Androgen Antagonists / Q000494:pharmacology; D000818:Animals; D004341:Drug Evaluation; D004965:Estrogen Antagonists / Q000494:pharmacology; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008297:Male; D051379:Mice; D008968:Molecular Conformation; D011247:Pregnancy; D045167:Progesterone Congeners / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011467:Prostate / Q000187:drug effects; D051381:Rats; D011980:Receptors, Progesterone / Q000187:drug effects; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism; D013329:Structure-Activity Relationship; D014621:Vagina / Q000187:drug effects; D014770:Virilism / Q000139:chemically induced
D000726:Androgen Antagonists; D004965:Estrogen Antagonists; D045167:Progesterone Congeners; D011980:Receptors, Progesterone; D012738:Sex Hormone-Binding Globulin